Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2025-12-25 @ 11:54 AM
NCT ID: NCT01311661
Description: Time frame for adverse event reporting includes 12 days into the subsequent washout or post-treatment period.
Frequency Threshold: 5
Time Frame: 3 weeks treatment period + 12 days
Study: NCT01311661
Study Brief: A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Matching Placebo delivered by the Respimat Inhaler. Two actuations bid (morning and evening dosing). None None 2 201 0 201 View
Olo 2.5 mcg Bid Olodaterol 2.5 mcg bid delivered by the Respimat Inhaler. None None 1 101 0 101 View
Olo 5 mcg qd Olodaterol 5 mcg qd (morning) and matching Placebo in the evening delivered by the Respimat Inhaler. None None 0 101 0 101 View
Olo 5 mcg Bid Olodaterol 5 mcg bid delivered by the Respimat Inhaler. None None 1 101 0 101 View
Olo 10 mcg qd Olodaterol 10 mcg qd (morning) and matching Placebo in the evening delivered by the Respimat Inhaler. None None 0 102 0 102 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Diverticulitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.1 View
Concussion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 14.1 View
Fall SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 14.1 View
Laceration SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 14.1 View
Meniscus lesion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 14.1 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 14.1 View
Other Events(If Any):